Overview
Pz Cormay is a Polish manufacturer and distributor of high-quality diagnostic reagents and reliable IVD technology. The company offers a comprehensive range of laboratory analyzers and reagents for biochemistry, hematology, immunochemistry, and general analytics, serving small, medium, and large laboratories. Additionally, they provide integrated systems for point-of-care diagnostics and automation in hematological diagnostics.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 0.50
- High
- PLN 0.54
- Low
- PLN 0.50
- Volume
- 79.1K
- Avg. vol.
- 42.45K
- Market cap
- PLN 44.80M
- P/E ratio
- –
- EPS
- -PLN 0.05
- Shares outstanding
- 84.21M
- 52-week
- PLN 0.50 – 0.55
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLCMRAY00029
- Exchange
- GPW Main Market
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 7.28m | USD 166.94k | USD -23.50k |
| Q1 2026 | USD 6.28m | USD -314.69k | USD -618.85k |
| Q4 2025 | USD 6.39m | USD -373.93k | USD -448.27k |
| Q3 2025 | USD 6.40m | USD 28.88k | USD -107.99k |
Results for Q3 2026:Nov 27, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2006-12-08. Active
17 1090 2688 0000 0001 2121 3545- 02 1090 2688 0000 0001 2120 6540
- 40 1090 2590 0000 0001 5729 6999
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
37 public aid cases recorded, with a total value of $2,146,947.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 15, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,960$1,960 | Marszałek Województwa Lubelskiego | |
| Jan 28, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $27,012$27,012 | Marszałek Województwa Lubelskiego | |
| Jan 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $801$801 | PGE Obrót S.A. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2024-09-01 | Wzrost konkurencyjności firmy PZ Cormay S.A. poprzez internacjonalizację oferty na zagranicznych imprezach targowych dla branży sprzętu medycznego Medlab2025 | $59,983$59,983 | Fundusze Europejskie dla Lubelskiego 2021-2027 | |
| 2023-10-19 | Wzrost konkurencyjności firmy PZ Cormay S.A. poprzez internacjonalizację oferty na zagranicznych imprezach targowych dla branży sprzętu medycznego | $46,820$46,820 | Fundusze Europejskie dla Lubelskiego 2021-2027 | |
| 2023-07-01 | Realizacja prac badawczo-wdrożeniowych nad opracowaniem i wprowadzeniem na rynek nowego analizatora hematologicznego Qube | $305.2K$305,244 | Fundusze Europejskie dla Lubelskiego 2021-2027 |
Tenders
210 tenders recorded as contractor: 122 national ($5,755,043) and 88 EU ($50,974,299).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 13, 2026 | Sukcesywna dostawa podstawowych wyrobów medycznych na potrzeby Powiatowego Centrum Zdrowia Sp. z o.o. w Kartuzach | –– | Powiatowe Centrum Zdrowia | |
| Sep 29, 2026 | Postępowanie o udzielenie zamówienia publicznego w trybie przetargu nieograniczonego na dostawę odczynników i drobnego sprzętu na potrzeby Zakładu Diagnostyki Laboratoryjnej | –– | Uniwersytecki Szpital Dziecięcy w Lublinie | |
| Sep 21, 2026 | Dostawa paneli syndromicznych do systemu Biofire, odczynników do oznaczania hemoglobiny glikowanej z dzierżawą aparatu, odczynników do badań immunochemicznych wraz z dzierżawą analizatorów i systemu pre/poanalitycznego, odczynników do badań endokrynologicznych z zakresu chorób metabolicznych i zakaźnych z dzierżawą analizatora oraz odczynników immunochemicznych hormonalnych z dzierżawą aparatu | –– | Mazowiecki Szpital Bródnowski sp. z o.o. |
Public sector contracts
PZ Cormay is the contractor in 47 public sector contracts, worth PLN 3.76m in total. They were signed with 34 public buyers. The largest number (2) were signed with Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie.
| Public buyer | Value | |
|---|---|---|
| Akademia Wychowania Fizycznego Im.Eugeniusza Piaseckiego w Poznaniu | PLN 2,693 | |
| Akademia Wychowania Fizycznego Im.Eugeniusza Piaseckiego w Poznaniu | PLN 5,204 | |
| Uniwersytet w Siedlcach | PLN 455.00 | |
| Samodzielny Publiczny Zakład Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie | PLN 5,600 | |
| Szpital Rejonowy Im. Dr Józefa Rostka w Raciborzu | PLN 1,050 |
Public procurement disputes (KIO)
PZ Cormay has been a party to 9 cases before the National Appeal Chamber (since 2012). It filed 6 appeals (2 upheld, 2 dismissed, 2 discontinued). In 3 cases it joined the proceedings as a participant.
Trademarks
PZ Cormay holds 2 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 1992.
| Mark | Protected until | |
|---|---|---|
| CORMAY(word) | Dec 10, 2027 | |
| LIQUICK(word) | Nov 22, 2026 | |
| CORMAY | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy are authorized to represent the company and make declarations on behalf of the company.
Supervisory board
Beneficial owners
No beneficial owners recorded for the company PZ Cormay.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Avantor Performance Materials PolandS.A. | $158,671,650.57 | poch.com.pl | ||
| BiomaximaS.A. | $14,936,464.09 | biomaxima.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-12-01 | PKD change (Removed: 46.90.Z; Added: 46.46.Z) | |
| 2018-10-31 | Share capital change (77,205,008.00 PLN → 84,205,008.00 PLN) | |
| 2017-11-14 | Share capital change (63,723,954.00 PLN → 77,205,008.00 PLN) | |
| 2015-09-25 | Share capital change (31,861,977.00 PLN → 63,723,954.00 PLN) | |
| 2015-04-27 | PKD change (Removed: 18, 20.12.Z, 20.13.Z, 20.14.Z, 20.15.Z, 20.16.Z, 20.17.Z, 20.20.Z, 20.30.Z, 20.41.Z, 20.42.Z, 20.52.Z, 20.53.Z, 20.60.Z, 23, 25, 27, 28, 32.50.Z, 32.99.Z, 33.11.Z, 33.12.Z, 33.14.Z, 33.19.Z, 46.1, 46.3, 46.4, 46.5, 46.6, 46.7, 47.2, 47.4, 47.73.Z, 47.74.Z, 47.75.Z, 47.78.Z, 47.79.Z, 47.9, 49.3, 58, 62, 63.9, 64.9, 68, 71.2, 73, 74, 82.30.Z, 85.59, 85.60.Z, 86.90.E, 93, 95; Added: 70) |
FAQ
Last updated: 2026-06-18